Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.38% | 43.84% | 43.96% | 42.27% | 34.23% |
| Total Depreciation and Amortization | -71.33% | -63.06% | -48.03% | -28.69% | -9.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.76% | -84.38% | -72.00% | -57.95% | -29.97% |
| Change in Net Operating Assets | -115.65% | 996.62% | 1,439.58% | 3,272.55% | 3,697.60% |
| Cash from Operations | -324.76% | 132.69% | 131.96% | 134.59% | 126.93% |
| Capital Expenditure | 89.02% | 46.20% | -56.67% | -163.73% | -150.00% |
| Sale of Property, Plant, and Equipment | -- | -98.40% | -98.40% | -98.40% | -98.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 158.34% | -219.43% | -199.80% | -193.09% | -177.21% |
| Cash from Investing | 158.10% | -215.40% | -197.51% | -191.53% | -176.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 113.12% | 327.53% | 327.53% | 82.65% | 2,150.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 113.12% | 327.53% | 327.53% | 82.65% | 2,150.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.80% | 106.41% | 88.74% | -221.54% | -579.71% |